Pelaia, G., Vatrella, A., Busceti, M. T., Gallelli, L., Preianò, M., Lombardo, N., . . . Maselli, R. (2016). Role of biologics in severe eosinophilic asthma – focus on reslizumab. Ther Clin Risk Manag.

Pelaia, Girolamo, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Mariaimmacolata Preianò, Nicola Lombardo, Rosa Terracciano, und Rosario Maselli. "Role of Biologics in Severe Eosinophilic Asthma – Focus On Reslizumab." Ther Clin Risk Manag 2016.

Pelaia, Girolamo, et al. "Role of Biologics in Severe Eosinophilic Asthma – Focus On Reslizumab." Ther Clin Risk Manag 2016.